Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP142) administered intramuscularly with adjuvant system AS01
Title:
Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP142) administered intramuscularly with adjuvant system AS01
Author:
Otsyula, Nekoye Angov, Evelina Bergmann-Leitner, Elke Koech, Margaret Khan, Farhat Bennett, Jason Otieno, Lucas Cummings, James Andagalu, Ben Tosh, Donna Waitumbi, John Richie, Nancy Shi, Meng Miller, Lori Otieno, Walter Otieno, Godfrey Allan Ware, Lisa House, Brent Godeaux, Olivier Dubois, Marie-Claude Ogutu, Bernhards Ballou, W Ripley Soisson, Lorraine Diggs, Carter Cohen, Joe Polhemus, Mark Heppner, D Gray Ockenhouse, Christian F Spring, Michele D